Lite Strategy, Inc.
LITS
$1.21
-$0.04-3.20%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
2/17/2026
-
The Fly
2/17/2026
-
TipRanks Financial Blog
2/17/2026
-
The Fly
2/17/2026
-
The Fly
2/17/2026
-
Globe Newswire
2/15/2026
-
Ticker Report
2/12/2026
-
TipRanks Financial Blog
1/14/2026
-
MarketBeat
12/24/2025
-
Simply Wall St
12/23/2025
-
MarketBeat
12/22/2025
-
Ticker Report
12/22/2025
-
MarketBeat
12/22/2025
-
MarketBeat
12/22/2025
-
GuruFocus
11/23/2025
-
MarketBeat
11/20/2025
-
GuruFocus
11/19/2025
-
GuruFocus
11/19/2025
-
TipRanks Financial Blog
11/19/2025
-
The Fly
11/18/2025
-
TipRanks Financial Blog
11/17/2025
-
TipRanks Financial Blog
11/17/2025
-
GuruFocus
11/17/2025
-
The Fly
11/17/2025
-
GuruFocus
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Tuesday, February 17, 2026
Period Date
Wednesday, December 31, 2025
Next Filing
Week of May 11 and 15 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
858 369 7100
Address
9920 Pacific Heights Blvd.
San Diego, CA 92121
San Diego, CA 92121
Country
Year Founded
Business Description
Sector
Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. The company was formerly known as MEI...
more